|
1.
|
|
23 p, 1.3 MB |
European guideline (EuroGuiDerm) on atopic eczema - part II : non-systemic treatments and treatment recommendations for special AE patient populations
/
Wollenberg, Andreas (Brussels University Hospital) ;
Kinberger, Maria (Charité - Berlin University Medicine) ;
Arents, B. (European Federation of Allergy and Airways Diseases Patients' Associations) ;
Aszodi, N. (LMU Munich) ;
Avila Valle, G. (Charité - Berlin University Medicine) ;
Barbarot, Sebastien (Nantes University) ;
Bieber, T. (University Hospital of Bonn) ;
Brough, H.A. (King's College London) ;
Calzavara Pinton, P. (University of Brescia) ;
Christen-Zäch, S. (Lausanne University Hospital) ;
Deleuran, M. (Aarhus University Hospital) ;
Dittmann, M. (Charité - Berlin University Medicine) ;
Dressler, C. (Charité - Berlin University Medicine) ;
Fink-Wagner, A.H. (Global Allergy and Airways diseases Patient Platform) ;
Fosse, N. (University Hospital Basel) ;
Gáspár, K. (University of Debrecen) ;
Gerbens, L. (Amsterdam UMC) ;
Gieler, U. (University of Giessen) ;
Girolomoni, Giampiero (University of Verona) ;
Gregoriou, S. (National and Kapodistrian University of Athens) ;
Mortz, C. G. (University of Southern Denmark) ;
Nast, A. (Charité - Berlin University Medicine) ;
Nygaard, U. (Aarhus University Hospital) ;
Redding, M. (Eczema Outreach Support) ;
Rehbinder, E.M. (Oslo University Hospital) ;
Ring, J. (Technical University Munich) ;
Rossi, M. (Spedali Civili Hospital Brescia) ;
Serra-Baldrich, E (Institut d'Investigació Biomèdica Sant Pau) ;
Simon, D. (University of Bern) ;
Szalai, Z.Z. (Heim Pál National Children's Institute Budapest) ;
Szepietowski, J.C. (Wrocław Medical University) ;
Torrelo, A. (Hospital Infantil Niño Jesús) ;
Werfel, T. (Hannover Medical School) ;
Flohr, C. (Guy's & St Thomas' NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. [...]
2022 -  10.1111/jdv.18429
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 11 (november 2022) , p. 1904-1926
|
|
|
2.
|
|
23 p, 887.0 KB |
European guideline (EuroGuiDerm) on atopic eczema : part I - systemic therapy
/
Wollenberg, A. (Universitair Ziekenhuis Brussel) ;
Kinberger, M. (Charité - Universitätsmedizin Berlin) ;
Arents, B. (European Federation of Allergy and Airways Diseases Patients' Associations) ;
Aszodi, N. (LMU Munich) ;
Avila Valle, G. (Charité - Universitätsmedizin Berlin) ;
Barbarot, Sebastien (Nantes Université) ;
Bieber, T. (University Hospital of Bonn) ;
Brough, H.A. (King's College London) ;
Calzavara Pinton, P. (University of Brescia) ;
Christen-Zäch, S. (Lausanne University Hospital) ;
Deleuran, M. (Aarhus University Hospital) ;
Dittmann, M. (Charité - Universitätsmedizin Berlin) ;
Dressler, C. (Charité - Universitätsmedizin Berlin) ;
Fink-Wagner, A.H. (Global Allergy and Airways Diseases Patient Platform) ;
Fosse, N. (University Hospital Basel) ;
Gáspár, K. (University of Debrecen) ;
Gerbens, L. (Amsterdam UMC) ;
Gieler, U. (University of Giessen) ;
Girolomoni, Giampiero (University of Verona) ;
Gregoriou, S. (National and Kapodistrian University of Athens) ;
Mortz, C. G. (University of Southern Denmark) ;
Nast, A. (Charité - Universitätsmedizin Berlin) ;
Nygaard, U. (Aarhus University Hospital) ;
Redding, M. (Eczema Outreach Support) ;
Rehbinder, E.M. (Oslo University Hospital) ;
Ring, J. (Technical University Munich) ;
Rossi, M. (Spedali Civili Hospital Brescia) ;
Serra-Baldrich, E (Institut d'Investigació Biomèdica Sant Pau) ;
Simon, D. (University of Bern) ;
Szalai, Z.Z. (Heim Pál National Children's Institute Budapest) ;
Szepietowski, J.C. (Wroclaw Medical University) ;
Torrelo, A. (Hospital Infantil Niño Jesús) ;
Werfel, T. (Hannover Medical School) ;
Flohr, C. (Guy's & St Thomas' NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. [...]
2022 - 10.1111/jdv.18345
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 9 (september 2022) , p. 1409-1431
|
|
|
3.
|
|
7 p, 283.2 KB |
A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features : results from psoriasis patients in Spain
/
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
van de Kerkhof, P. C. M. (Radboud University Nijmegen Medical Centre) ;
Reich, Kristian (Sclderm Research Institute and Dermatologikum Hamburg) ;
Bachelez, Hervé (Sorbonne Paris Cité Université Paris Diderot) ;
Barker, J.N (King's College London) ;
Girolomoni, G. (University of Verona) ;
Paul, C. (Paul Sabatier University and Larrey Hospital) ;
Universitat Autònoma de Barcelona
The Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey data were not analysed to account for cultural and healthcare system differences across European countries (EC). To utilize MAPP data to characterize psoriasis in Spanish patients, including severity assessment and Dermatology Life Quality Index (DLQI). [...]
2017 - 10.1111/jdv.14195
Journal of the European Academy of Dermatology and Venereology, Vol. 31 Núm. 7 (july 2017) , p. 1176-1182
|
|
|
4.
|
|
10 p, 1.7 MB |
Epidemiology of atopic dermatitis in adults : Results from an international survey
/
Barbarot, Sebastien (CHU Nantes) ;
Auziere, S. (Kantar Health) ;
Gadkari, A. (Regeneron) ;
Girolomoni, G. (University of Verona) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Simpson, E.L. (Oregon Health & Science University) ;
Margolis, D.J. (University of Pennsylvania Perelman School of Medicine) ;
de Bruin-Weller, Marjolein (University Medical Center Utrecht) ;
Eckert, L. (Sanofi) ;
Universitat Autònoma de Barcelona
There are gaps in our knowledge of the prevalence of adult atopic dermatitis (AD). To estimate the prevalence of AD in adults and by disease severity. Methods: This international, cross-sectional, web-based survey was performed in the United States, Canada, France, Germany, Italy, Spain, United Kingdom, and Japan. [...]
2018 - 10.1111/all.13401
Allergy, Vol. 73 Núm. 6 (june 2018) , p. 1284-1293
|
|
|
5.
|
|
10 p, 1.5 MB |
Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis : analysis of pooled data from the randomized trials SOLO 1 and SOLO 2
/
Cork, M.J. (University of Sheffield Medical School) ;
Eckert, L. (Sanofi) ;
Simpson, E.L. (Oregon Health & Science University) ;
Armstrong, A. (Keck School of Medicine at USC. University of Southern California) ;
Barbarot, Sebastien (CHU Hôtel-Dieu) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Girolomoni, G. (University of Verona) ;
de Bruin-Weller, Marjolein (University Medical Center Utrecht) ;
Wollenberg, A. (Klinikum der Universität München) ;
Kataoka, Y. (Osaka Habikino Medical Center) ;
Remitz, A. (Helsinki University Central Hospital) ;
Beissert, Stefan (Technische Universität Dresden) ;
Mastey, V. (Regeneron Pharmaceuticals Inc.) ;
Ardeleanu, Marius (Regeneron Pharmaceuticals Inc.) ;
Chen, Z. (Regeneron Pharmaceuticals Inc.) ;
Gadkari, A. (Regeneron Pharmaceuticals Inc.) ;
Chao, J. (Regeneron Pharmaceuticals Inc.) ;
Universitat Autònoma de Barcelona
Atopic dermatitis (AD) profoundly affects quality of life (QoL). Dupilumab significantly improves clinical outcomes, is well tolerated, and approved to treat inadequately controlled moderate-to-severe AD in adults; however, its effect on patient-reported outcomes (PROs) is not fully characterized. [...]
2020 - 10.1080/09546634.2019.1612836
Journal of Dermatological Treatment, Vol. 31 Núm. 6 (17 2020) , p. 606-614
|
|
|
6.
|
|
20 p, 2.2 MB |
Nomenclature and clinical phenotypes of atopic dermatitis
/
Girolomoni, Giampiero (University of Verona) ;
de Bruin-Weller, Marjolein (University Medical Center (Utrecht, Netherlands)) ;
Aoki, Valeria (University of São Paulo School of Medicine) ;
Kabashima, Kenji (Kyoto University Graduate School of Medicine) ;
Deleuran, Mette (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Bansal, Ashish (Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA)) ;
Rossi, Ana Beatris (Sanofi Genzyme (Cambridge, Estats Units))) ;
Universitat Autònoma de Barcelona
Atopic dermatitis is a heterogeneous disease and resists classification. In this review, we discuss atopic dermatitis nomenclature and identify morphologic phenotypes, which will facilitate correct diagnoses and development of treatment strategies. [...]
2021 - 10.1177/20406223211002979
Therapeutic Advances in Chronic Disease, Vol. 12 (march 2021)
|
|
|
7.
|
|
11 p, 351.3 KB |
The patient-reported disease burden in adults with atopic dermatitis : a cross-sectional study in Europe and Canada
/
de Bruin-Weller, Marjolein (University Medical Center Utrecht) ;
Gadkari, Abhijit (Regeneron Pharmaceuticals. Inc) ;
Auziere, S. (Kantar - Health Division) ;
Simpson, E. L. (Oregon Health and Science University) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Barbarot, Sebastien (Centre Hospitalier Universitaire de Nantes) ;
Girolomoni, Giampiero (Universita di Verona) ;
Papp, K. (Probity Medical Research, Waterloo) ;
Pink, A. E. (St. John's Institute of Dermatology, Guy's and St. Thomas' NHS Foundation Trust and Kings College London) ;
Saba, G. (Kantar - Health Division) ;
Werfel, T. (Hannover Medical University) ;
Eckert, Laurent (Sanofi) ;
Universitat Autònoma de Barcelona
Cross-sectional data on patient burden in adults with atopic dermatitis () from real-world clinical practice are limited. This study compared patient-reported burden associated with adult across severity levels from clinical practices in Canada and Europe. [...]
2020 - 10.1111/jdv.16003
Journal of the European Academy of Dermatology and Venereology, Vol. 34 (january 2020) , p. 1026-1036
|
|
|
8.
|
|
11 p, 1.5 MB |
The role of IL-23 and the IL-23/TH17 immune axis in the pathogenesis and treatment of psoriasis
/
Girolomoni, Giampiero (University of Verona) ;
Strohal, Robert (Federal Academic Teaching Hospital of Feldkirch) ;
Puig Sanz, Lluís (Universitat Autònoma de Barcelona) ;
Bachelez, Hervé (Institut Imagine (Paris, França)) ;
Barker, Jonathan (King's College London) ;
Boehncke, Wolf-Henning (University of Geneva) ;
Prinz, Joerg (University of Munich)
Psoriasis is a chronic, immune-mediated disease affecting more than 100 million people worldwide and up to 2. 2% of the population. The aetiology of psoriasis is thought to originate from an interplay of genetic, environmental, infectious and lifestyle factors. [...]
2017 - 10.1111/jdv.14433
Journal of the European Academy of Dermatology and Venereology, Vol. 31, Issue 10 (October 2017) , p. 1616-1626
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
